Background: Although studies have shown that complementary and alternative medicine (CAM) use is common in cancer patients, no survey has assessed CAM use in men with a variety of cancers. In Australia, no data exist about male cancer patients' use of CAM.
introduction
Complementary and alternative medicines (CAMs) are defined as 'diverse medical and health care systems, practices, and products that are not generally considered part of conventional medicine' [1] . There is some data to suggest that, as a complement to conventional treatment, their use may be beneficial to reduce common treatment side-effects and disease symptoms [2] [3] [4] . For example, acupuncture and acupressure may relieve chemotherapy-induced nausea and vomiting [5, 6] , and cancer-related pain can be reduced by acupuncture [7] , hypnosis [8] , therapeutic touch [9] , and massage [7] . Exercise [10] , therapeutic touch [11] , meditation and relaxation techniques [12] benefit fatigue.
There is also evidence that CAMs contribute to mental health and emotional well-being in cancer patients. Yoga [13] , meditation [12] , and exercise [14] help to reduce stress in cancer patients and contribute to patients' quality of life.
Meditation and relaxation techniques [12, 15] can also reduce anxiety and depressive symptoms in cancer patients.
The popularity of CAM use in cancer sufferers presumably reflects the benefits, real or perceived, by those who use them. In a 1998 systematic review including 26 surveys from 13 countries, it has been found that between 7% and 64% (average of 31.4%) of adult cancer patients used CAMs [16] . There is evidence that rate of CAM use has increased, at least in breast cancer populations, from 67% to 82% during the years 1998-2005 [17] . In the United States, where most studies relating to CAM use have been conducted, up to 90% of cancer patients use CAM [18] [19] [20] [21] [22] . In Australia, there are limited data available for cancer patients' use of CAM; older studies reported that they are used by 22%-85% of patients [23, 24] . Recent studies, ranging in size from 200 to 381 participants, reported that 30%-65% of cancer patients use CAM [25, 26] . Among CAM users, 61% were breast cancer patients [26] , consistent with the observation that the majority of studies relating to CAM use in cancer sufferers have been undertaken in women [27] [28] [29] . North American and European surveys including men, almost exclusively those with prostate cancer, suggest that CAM use in men ranges from 25% to 40% [30] [31] [32] .
In patients (mostly men) with head and neck cancer, CAM use has been reported to be under 25% [33, 34] .
The objective of this study was to determine, in men attending Australian cancer outpatient services, (i) the extent and types of CAM used; (ii) the sociodemographic, personal, and clinical characteristics associated with use of CAM; and (iii) to identify which CAMs have been discussed within the cancer patient's social network.
patients and methods

participants
A consecutive series of males with cancer receiving chemotherapy or/and radiotherapy at two public and two private outpatient cancer clinics in Adelaide, South Australia, were approached by NK and asked to complete a questionnaire. Additional inclusion criteria included age over 18 years, ability to provide informed consent, and communicate in English. Those who were particularly unwell were excluded. The study was approved by the Human Research Ethics Committees at both hospitals and The University of Adelaide.
questionnaire
We used a modified version of two questionnaires published by Richardson et al. [19] and Miller et al. [24] . The questionnaire was developed through a systematic literature review, discussions by experienced medical oncologists and health professionals, and input from a cancer advocacy organization.
The first section of the questionnaire asked patients about sociodemographic details. The second section assessed patients' use of CAM. Categories of CAM (see Tables A2 and A3 for full list) were based on the widely established taxonomy of the National Center for Complementary and Alternative Medicine (NCCAM) [1] but also included CAM described within the literature as used by cancer patients to help manage or cope with their disease or treatment side-effects, including prayer, psychological therapies, support groups, and physiotherapy. In the third section, patients indicating having ever used any CAM (i.e. CAM users, CAM ex-users) were specifically asked which of the CAM therapies (to a maximum of three) they used had evoked the strongest reaction in other people, the information source for this CAM, and who was involved in any discussions about its use. In the fourth section, all patients were asked which CAM therapy anyone suggested they should use but they did not use.
Demographic information collected included birth date, marital status, country of birth, postcode, religion, actively practicing religion, education level, and private health insurance. Socioeconomic status (SES) was determined from the Australian Bureau of Statistics (ABS) Socioeconomic Index of relative socioeconomic advantage and disadvantage (SEIFA) [35] . The postcode of patients' residence was used to allocate a SEIFA score ranging from 1 to 10, with a lower score indicating more social and economic disadvantage. These scores were used to create the categories of the variable SES: SEIFA scores 1-3, 4-7, and 8-10 were classified as low, moderate, and high SES, respectively. Patient postcode was also used to allocate Rural, Remote, and Metropolitan Area (RRMA) scores developed by the Australian Government Department of Health and Ageing [36] . The three zones of the RRMA classification were used as categories for the variable geographical area. The variable education consisted of the categories primary, secondary (years 10 and 12), and tertiary (tertiary nonuniversity, tertiary university, postgrad) education. Medical information (type of cancer, stage of cancer, past and present medical treatment received) was extracted from patients' medical records within the clinics' databases.
statistical analysis
Differences between CAM users and nonusers with regard to sociodemographic (age group, relationship status, country of birth, geographical area, religion, private health insurance, SES, actively practicing religion, education) and medical variables (type of cancer, past and present medical treatment, stage of cancer) were assessed using Pearson's v 2 tests.
All variables were categorical. Significant variables (P < 0.05) were analyzed in univariate and multivariate logistic regression analyses to assess their association with general use of CAM (coded as a dichotomous outcome variable), as well as with specific CAM categories. All analyses provided an odds ratio and were reported with 95% confidence intervals (CIs) for each variable. P-values were two-sided.
The multivariate logistic regression analysis was conducted by using the forced entry method. This is an appropriate method for theory testing, in which all potential predictor variables are put into one block to analyze their own contribution to the final model while simultaneously controlling for the effect of other variables [37] . Finally, the Hosmer-Lemeshow v 2 test
was carried out to assess how well the predictors fit the model [38] . Since this statistic tests the hypotheses that the predicted outcomes differ significantly from the observed outcomes, a P-value >0.05 is considered a good fit. All data analyses were conducted by using the Statistical Package In this male cancer population, 81.4% reported that they had heard about using CAM as a complement for cancer treatment, 61.5% reported that they have experience with CAM during cancer treatment, and 52.9% indicated that they were currently using CAM while receiving conventional medical treatment.
differences between CAM users and nonusers
By v 2 tests, CAM users differed from nonusers with regard to four variables: stage of cancer (P = 0.045), SES (P = 0.047), actively practicing religion (P < 0.001), and education (P = 0.043) (see supplemental Table S1 , available at Annals of Oncology online). There were no differences with respect to type of cancer, past and present medical treatment, cancer clinic, hospital, age group, relationship status, country of birth, geographical area, religion, and private health insurance.
Univariate logistic regression analyses indicated that patients with metastatic cancer were 1.54 times (95% CI 1.03-2.31, P = 0.035) more likely to use CAM than patients with nonmetastatic cancer, patients of moderate SES were 1.84 times (95% CI 1.13-2.98, P = 0.014) more likely to use CAM than patients with lower SES, patients actively practicing religion were 4.79 times (95% CI 2.72-8.43, P < 0.001) more likely to use CAM than patients not actively practicing religion, and original articles Annals of Oncology patients with primary education were less likely (95% CI 0.36-0.9, P = 0.016) to use CAM than patients with tertiary education (Table A1) .
CAM users and nonusers of the CAM category 'mind-body medicine' differed (v 2 , P < 0.05) with regard to actively practicing religion, education, SES, geographical area, religion, and hormonal therapy (see supplemental Table S2 , available at Annals of Oncology online). This analysis was repeated excluding psychology/counseling, support groups, and prayer as some have suggested that these therapies do not belong to CAM [39] , with differences found (v 2 , P < 0.05) with regard to age group, education, and actively practicing religion (see supplementary Table S3 , available at Annals of Oncology online).
There were no differences (v 2 , P > 0.05) found in the use of different CAM categories or the use of the most popular CAM therapies with regard to type of cancer.
predictors of CAM use
When the four potential predictor variables (stage of cancer, SES, actively practicing religion, education) and two interactions between the potential predictors (education by SES, actively practicing religion by education) were entered into a multivariate logistic regression model, use of CAM was predicted [v 2 (12) = 64.16, P < 0.001] by stage of cancer, actively practicing religion, and education only (Table A1 ). The interaction education by SES was significant (P = 0.025), while actively practicing religion by education was not significant (P = 0.784) in the multivariate analysis.
Patients with metastatic cancer were 1.68 times (95% CI 1.08-2.61, P < 0.022) more likely to use CAM than patients with nonmetastatic cancer, patients actively practicing religion were 4.92 times (95% CI 1.51-16.07, P < 0.008) more likely to use CAM than patients not actively practicing religion, and patients with tertiary education were 5.54 times (95% CI 1.58-19.04, P < 0.007) more likely to use CAM than patients with primary education. The multivariate logistic regression model suggested a satisfactory fit [v 2 (8) = 6.9; P = 0.55] between the predicted and observed outcomes for the final model.
Within the category mind-body medicine, CAM use was predicted [v 2 (15) = 94.94, P < 0.001] by actively practicing religion (P = 0.01) and tertiary education (P = 0.016) only (see supplemental Table S4 , available at Annals of Oncology online). The interaction effect education by SES was significant (P = 0.037), while the interaction actively practicing religion by education was not significant (P = 0.383) in the multivariate analysis. The final model indicated a satisfactory fit [v 2 (7) = 2.78, P = 0.91] between obtained and observed outcomes. When psychology/counseling, support groups, and prayer were excluded, use of mind-body medicine was predicted [v 2 (11) = 48.84, P < 0.001] by younger age group (P = 0.007) and higher education (P = 0.039) (see supplemental Table S5 , available at Annals of Oncology online). Both interactions, actively practicing religion by education (P = 0.607) and actively practicing religion by age group (P = 0.572), were not significant in the multivariate analysis. A satisfactory fit [v 2 (7) = 1.99, P = 0.96] between the obtained and expected outcomes for the final model was obtained.
types of CAM used by patients
The frequencies of all CAM therapies used are listed in Tables A2  and A3 . The most popular CAM was dietary supplements: 26.6% of participants were currently using products ranging from aloe vera to vitamins concurrent with conventional medical treatment, and 36.6% used them at some stage. A further 19.7% had heard about its use during cancer treatment. Regarding other most popular CAMs, between 15% and 26% of respondents reported having ever used prayer, herbs and botanicals, and relaxation techniques/meditation during cancer treatment. Table A2 specifically highlights those natural products that are known to interact with conventional medical treatment. Clinicians should advise their patients that, e.g. Echinacea or St John's wort might interact with chemotherapy agents [40] and Ginseng or Gingko biloba with other prescribed medication [41] .
which CAMs have been discussed and used by patients Only 9.9% of patients reported that their cancer specialist referred them to use CAM. CAM users and ex-users specified up to three therapies, which they have discussed with other people: dietary supplement use was mentioned most often, namely by 29% of male CAM users and ex-users, followed by herbs and botanicals (16%), prayer (13.5%), and relaxation techniques/meditation (13%). Nonparametric v 2 tests (v 2 = 46.11, 6 df, P < 0.001) indicated that family (35.8%) most often provided information about CAM treatments compared with friends (29.2%), medical professionals (23.1%), other sources (19.9%), media (8.5%), cancer patients (7.6%), and the Internet (4.3%). Family members (85.7%) were significantly more often (v 2 = 10.78, 1 df, P < 0.001) involved in patients' discussions about CAM use than medical professionals (48.4%) including also health care staff other than oncologists and hematologists.
Information sources differed with regard to type of CAM: the use of dietary supplements was significantly more often (v 2 = 68.31, 6 df, P = 0.001) informed by family (46%) compared with medical professionals (30%), friends (22%), media (15%), other sources (12%), cancer patients (6%), and the Internet (4%). Users of herbs and botanicals were significantly more often (v 2 = 29.19, 3 df, P = 0.001) informed by friends (43%) compared with family (38%), media (8%), cancer patients (8%), the Internet (8%), other (8%), and medical professionals (5%). Patients using prayer found information about its use significantly more often (v 2 = 42.39, 3 df, P = 0.001) provided by family (55%) compared with other sources (39%), friends (24%), medical professionals (3%), and the media (3%).
which CAMs have been discussed but not used by patients All participants-CAM users, ex-users, and nonusers-specified one CAM therapy which was strongly recommended by other people but not used by the patient: dietary supplement use was mentioned by 3.5% of the whole study sample, followed by herbs and botanicals (2%) and natural medication (1.5%). Nonparametric v 2 tests (v 2 = 125.3, 6 df, P < 0.001) revealed that friends (63.1%) most often provided information about CAM therapies not used by the Annals of Oncology original articles patients, followed by family (30.8%), medical persons (13.8%), media (12.3%), cancer patients (10.8%), Internet (9.2%), and other sources (3.1%).
discussion
This study is the first to specifically assess CAM use by men with a variety of cancers in Australia, and it is one among the few representative studies available about men's use of CAM during cancer treatment. Previous North American and European studies specifically looking at the use of CAM by men have only included prostate and head and neck cancer patients [30] [31] [32] [33] [34] . The observation that two-thirds of the surveyed population had ever used CAM during cancer treatment is similar to recent data from cancer patients (men and women) in Sydney, Australia [26] , but higher than that reported in previous studies, which included men only [30] [31] [32] [33] [34] . This may be influenced by the overall increase in the popularity of CAM since the 1990s [42, 43] . Despite advances in medical treatment of cancer that have seen improvements in cure rates and survivorship [44] , the incidence of cancer is increasing, and it remains a leading cause of death [45] . At the same time, the use of CAM has increased in the cancer population [17] . From a clinical perspective, it is important to know why a substantial and increasing number of cancer patients decide to use treatments in addition to, but independent of, the conventional medical system. Several reasons for cancer patients' use of CAM have been suggested [46] , including perceived benefit from CAMs, wanting control about cancer diagnosis and its treatment, belief in the effectiveness of CAM, using CAM to try everything possible to increase survival, and receiving hope from CAM use. Cancer patients' use of CAM might also be explained with Lazarus and Folkmans' theory about stress and coping [47, 48] . According to these authors, coping is important for patients' functioning in daily life despite a chronic illness. They identified two general types of coping strategies: problemsolving efforts and emotion-focused coping. The use of dietary supplements or herbs and botanicals might reflect an attempt to ameliorate disease-related symptoms or side-effects of treatment. Practicing prayer or meditation techniques/ relaxation might constitute emotion-focused coping as patients embark on a spiritual search for meaning of life. Alternatively, Furnham and Smith [49] have suggested that patients are either (i) 'pushed' toward CAM because of dissatisfaction with conventional medical treatment or (ii) 'pulled' toward CAM because their philosophical beliefs and values are congruent with the paradigm proposed by CAM treatments. There are conflicting results within the academic literature regarding whether men with prostate cancer are 'pushed' or 'pulled' toward the use of CAM: Boon et al. [50] indicated in a qualitative focus group study that prostate cancer patients seem to be more pushed rather than pulled toward CAM. In contrast, Porter and Diefenbach [51] reported that CAM use in men with prostate cancer is better predicted by positive representations of CAM ('pulling effect') than by negative representations of conventional medicine ('pushing effect'). The current study suggests that CAM use in males is widespread and common not only in prostate cancer patients but also across all cancer types. More research is needed to better understand why a substantial number of men with cancer use CAM. While neither push nor pull factors appear to affect decisions about CAM use among breast cancer patients [52] , push factors appear important in prostate cancer patients' choice to use CAM [50] . Other data suggest that male cancer patients used CAM because of dissatisfaction with conventional treatment, related more to the social and emotional process of care than the treatment itself, or because of a strong spousal influence [53] . The current study supports the finding that significant others are involved in cancer patients' decision to use CAM [54] . The data show that information from friends is more likely to inform than promote use of CAMs, whereas a recommendation from family members is more likely to be followed.
The study highlights that dietary supplements, prayer, herbs and botanicals, and relaxation techniques/meditation are the most popular CAM therapies in this male cancer population. It is difficult to compare the popularity of CAM types with other male cancer populations in Europe or the United States, due to different measurements of CAM [30] [31] [32] [33] [34] . The use of CAM in men seems to differ between ethnical groups [55] , and in particular, the use of herbs and botanicals seems to be dependent upon tradition and thus varies between countries [56] . For example, mistletoe has a long tradition in Germanspeaking countries [57, 58] and has been reported to be beneficial as a complement during cancer treatment [59, 60] . Although the questionnaire used in the current study did not ask patients to report about specific herbs, in future research, it might be interesting to elucidate the most popular herbs in Australian cancer patients. Comparisons between countries might be better conducted when focusing on specific herbs, so that cultural differences of cancer incidence and/or preferences of herbal medicine might be better understood. In multicultural Australia, future research about CAM use in cancer patients might also focus on comparisons between different ethnic groups.
The broad definition of CAM used in the present study is clearly a limitation and the higher prevalence of CAM use in this sample compared with previous studies may be due to use of different measures of CAM [61] . Recently, there have been attempts to establish a standardized questionnaire about CAM [62] . As this questionnaire has not yet been validated in English, and was not specifically developed for cancer patients, it was not applied in this study. Another limitation is the inclusion of only English-speaking Caucasian cancer patients visiting outpatient cancer services. The sample was representative of the range and distribution of cancers that would be expected in men [63] , i.e. prostate, hematological malignancies, colorectal, lung, and other types, with the exception of melanoma, which is not typically treated in cancer outpatient services. The study participants were also representative with regard to age, geographical area, country of birth, and religion [44, [63] [64] [65] . As 94% of the approached patients agreed to participate, the results of the survey can be generalized to male cancer populations visiting public and private outpatient cancer services.
Oncologists should be aware that the majority of male cancer patients use CAM. Clinical consultations might benefit from an open discussion between clinicians and patients about the efficacy and safety about CAM. A better understanding of the original articles Annals of Oncology role, reasons for use, and benefits of CAMs may lead to more holistic approaches to care, and in particular opportunities to better address the social and emotional needs of men. 
